Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda

被引:171
作者
Weidle, Paul J.
Wamai, Nafuna
Solberg, Peter
Liechty, Cheryl
Sendagala, Sam
Were, Willy
Mermin, Jonathan
Buchacz, Kate
Behumbiize, Prosper
Ransom, Ray L.
Bunnell, Rebecca
机构
[1] Ctr Dis Control & Prevent, Epidemiol Branch, Div HIV AIDS Prevent, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA
[2] Global Programme AIDS, Ctr Dis Control & Prevent Uganda, Entebbe, Uganda
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
关键词
D O I
10.1016/S0140-6736(06)69118-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Poverty and limited health services in rural Africa present barriers to adherence to antiretroviral therapy that necessitate innovative options other than facility-based methods for delivery and monitoring of such therapy. We assessed adherence to antiretroviral therapy in a cohort of HIV-infected people in a home-based AIDS care programme that provides the therapy and other AIDS care, prevention, and support services in rural Uganda. Methods HIV-infected individuals with advanced HIV disease or a CD4-cell count of less than 250 cells per mu L were eligible for antiretroviral therapy. Adherence interventions included group education, personal adherence plans developed with trained counsellors, a medicine companion, and weekly home delivery of antiretroviral therapy by trained lay field officers. We analysed factors associated with pill count adherence (PCA) of less than 95%, medication possession ratio (MPR) of less than 95%, and HIV viral load of 1000 copies per mL or more at 6 months (second quarter) and 12 months (fourth quarter) of follow-up. Findings 987 adults who had received no previous antiretroviral therapy (median CD4-cell count 124 cells per mu L, median viral load 217 000 copies per mL) were enrolled between July, 2003, and May, 2004. PICA of less than 95% was calculated for 0.7-2.6% of participants in any quarter and MPR of less than 95% for 3.3-11.1%. Viral load was below 1000 copies per mL for 894 (98%) of 913 participants in the second quarter and for 860 (96%) of 894 of participants in the fourth quarter. In separate multivariate models, viral load of at least 1000 copies per mL was associated with both PICA below 95% (second quarter odds ratio 10.6 [95% CI 2.45-45.7]; fourth quarter 14.5 [2.51-83.6]) and MPR less than 95% (second quarter 9.44 [3.40-26.2]; fourth quarter 10.5 [4.22-25.9]). Interpretation Good adherence and response to antiretroviral therapy can be achieved in a home-based AIDS care Programme in a resource-limited rural African setting. Health-care systems must continue to implement, evaluate, and modify interventions to overcome barriers to comprehensive AIDS care programmes, especially the barriers to adherence with antiretroviral therapy.
引用
收藏
页码:1587 / 1594
页数:8
相关论文
共 30 条
[1]  
[Anonymous], PRES EM PLAN AIDS RE
[2]  
[Anonymous], 2003, SCAL ANT THER RES LT
[3]   Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda [J].
Bunnell, R ;
Ekwaru, JP ;
Solberg, P ;
Wamai, N ;
Bikaako-Kajura, W ;
Were, W ;
Coutinho, A ;
Liechty, C ;
Madraa, E ;
Rutherford, G ;
Mermin, J .
AIDS, 2006, 20 (01) :85-92
[4]   Adherence to HIV antiretroviral therapy in HIV plus Ugandan patients purchasing therapy [J].
Byakika-Tusiime, J ;
Oyugi, JH ;
Tumwikirize, WA ;
Katabira, ET ;
Mugyenyi, PN ;
Bangsberg, DR .
INTERNATIONAL JOURNAL OF STD & AIDS, 2005, 16 (01) :38-41
[5]   Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa [J].
Coetzee, D ;
Hildebrand, K ;
Boulle, A ;
Maartens, G ;
Louis, F ;
Labatala, V ;
Reuter, H ;
Ntwana, N ;
Goemaere, E .
AIDS, 2004, 18 (06) :887-895
[6]   Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa [J].
Coetzee, D ;
Boulle, A ;
Hildebrand, K ;
Asselman, V ;
Van Cutsem, G ;
Goemaere, E .
AIDS, 2004, 18 :S27-S31
[7]   Free antiretrovirals must not be restricted only to treatment naive patients [J].
Colebunders, R ;
Kamya, M ;
Semitala, F ;
Castelnuovo, B ;
Katabira, E ;
McAdam, K .
PLOS MEDICINE, 2005, 2 (10) :941-943
[8]   Adherence to first-line antiretroviral regimens in Rwanda [J].
Demeester, R ;
Omes, C ;
Karasi, JC ;
Schneider, S ;
Mugabo, J ;
Maliboli, MJ ;
Arendt, V .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 40 (01) :113-114
[9]  
Dezii C M, 2001, Manag Care, V10, P42
[10]   Virologic and immunologic outcomes and programmatic challenges of an antiretroviral treatment pilot project in Abidjan, Cote d'Ivoire [J].
Djomand, G ;
Roels, T ;
Ellerbrock, T ;
Hanson, D ;
Diomande, F ;
Monga, B ;
Maurice, C ;
Nkengasong, J ;
Konan-Koko, R ;
Kadio, A ;
Wiktor, S ;
Lackritz, E ;
Saba, J ;
Chorba, T .
AIDS, 2003, 17 :S5-S15